203 related articles for article (PubMed ID: 12626293)
1. [Case-control study of hepatitis C HBs Ag and antivirus antibodies in chronic hepatopathies].
Maiga MY; Dembele M; Maiga I; Sanago B; Sangare D; Traoré HA
Sante; 2002; 12(4):389-92. PubMed ID: 12626293
[TBL] [Abstract][Full Text] [Related]
2. [Study of antigen HBs and antivirus antibodies of hepatitis C during hepatopathies in Mali].
Dembele M; Maïga I; Minta D; Konate A; Diarra M; Sangare D; Traore HA; Maïga MY; Tounkara A; Payan C; Lunel E; Carbonnelle B; Cales P
Bull Soc Pathol Exot; 2004 Aug; 97(3):161-4. PubMed ID: 15462194
[TBL] [Abstract][Full Text] [Related]
3. [HBs Ag and antibodies to hepatitis C virus in complicated chronic liver disease in Gabon. A case control study].
Perret JL; Moussavou-Kombila JB; Delaporte E; Pemba LF; Boguikouma JB; Matton T; Larouze B
Gastroenterol Clin Biol; 2002 Feb; 26(2):131-5. PubMed ID: 11938063
[TBL] [Abstract][Full Text] [Related]
4. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
5. [Hepatitis C virus and chronic hepatopathies in Dakar: case-control study].
Mbaye PS; Renaudineau Y; Diallo A; Haudrechy D; Sane M; Michel G; Raphenon G; Klotz F
Med Trop (Mars); 2000; 60(1):47-52. PubMed ID: 10989787
[TBL] [Abstract][Full Text] [Related]
6. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
7. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of hepatitis D in a population of Northeast Mexico and its relationship with other viruses].
Muñoz Espinosa LE; Ibarra Salas MJ
Rev Gastroenterol Mex; 1997; 62(4):246-9. PubMed ID: 9580232
[TBL] [Abstract][Full Text] [Related]
9. [Hepatopathies associated with chronic carriage of HBs antigen in black African immigrants in France].
Meyniel D; Santoni JP; Gessain A; Grivaux M; Chatelet F; Pieron R
Sem Hop; 1983 Oct; 59(35):2465-70. PubMed ID: 6314528
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
Yokoi Y; Suzuki S; Baba S; Inaba K; Konno H; Nakamura S
J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between chronic liver diseases and hepatitis C in Burundi adults].
Aubry P; Larouze B; Muhirwa G; Henzel D; Ndabaneze E; Nsabimana JM
Med Trop (Mars); 1995; 55(3):235-7. PubMed ID: 8559018
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B surface antigen in hepatocellular carcinoma.
Tanaka K; Mori W
Jpn J Cancer Res; 1985 Jul; 76(7):603-7. PubMed ID: 2993215
[TBL] [Abstract][Full Text] [Related]
13. Anticardiolipin antibodies in chronic hepatitis B and chronic hepatitis D infection, and hepatitis B-related hepatocellular carcinoma. Relationship with portal vein thrombosis.
Elefsiniotis IS; Diamantis ID; Dourakis SP; Kafiri G; Pantazis K; Mavrogiannis C
Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):721-6. PubMed ID: 12811301
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection.
Ayoola EA; Gadour MO
J Gastroenterol Hepatol; 2004 Jun; 19(6):665-9. PubMed ID: 15151622
[TBL] [Abstract][Full Text] [Related]
16. [HBS antigen and liver diseases].
Blüger A; Kartaschowa O; Zalcmane V; Saldava L
Dtsch Z Verdau Stoffwechselkr; 1983; 43(2):56-64. PubMed ID: 6307637
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of hepatitis B and C viruses in patients with chronic kidney disease in the predialysis stage at a university hospital in Turkey.
Sit D; Kadiroglu AK; Kayabasi H; Yilmaz ME; Goral V
Intervirology; 2007; 50(2):133-7. PubMed ID: 17191015
[TBL] [Abstract][Full Text] [Related]
18. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma.
Hann HW; Lee J; Bussard A; Liu C; Jin YR; Guha K; Clayton MM; Ardlie K; Pellini MJ; Feitelson MA
Cancer Res; 2004 Oct; 64(20):7329-35. PubMed ID: 15492253
[TBL] [Abstract][Full Text] [Related]
19. [Occurrence of increased alpha-fetoprotein in non-neoplastic hepatopathies of alcoholic or non-alcoholic origin].
Pol S; Nalpas B; Bezeaud A; Bréchot C; Berthelot P
Gastroenterol Clin Biol; 1986 Feb; 10(2):112-6. PubMed ID: 2422087
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
